Apollo Medical Inc. (AMEH)
NASDAQ: AMEH
· Real-Time Price · USD
40.82
-0.88 (-2.11%)
At close: Feb 23, 2024, 10:00 PM
Apollo Medical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 10.22M | 6.22M | -8.01M | 23.7M | 21.87M | -94K | 27.97M | 17.48M | 12.49M | 471K | 23.9M | 11.28M | 11.45M | -19.31M | -5.38M | 59.53M | 14.46M |
Depreciation & Amortization | 6.9M | 6.85M | 15.08M | 7.26M | 7.44M | 4.9M | 4.3M | 4.25M | 4.29M | 4.06M | 4.75M | 4.35M | 4.37M | 4.41M | 4.67M | 4.24M | 4.2M |
Stock-Based Compensation | 11.71M | 7.81M | 21.17M | 6.16M | 7.39M | 8.68M | 5.71M | 4.21M | 3.44M | 5.62M | 3.5M | 3.92M | 3.06M | 2.42M | 1.42M | 1.56M | 1.35M |
Other Working Capital | n/a | n/a | n/a | n/a | n/a | -39.63M | 8.62M | 4.82M | 22.78M | 33.5M | -43.27M | -3.42M | 47.24M | 2.79M | -16.23M | -4.87M | 15.71M |
Other Non-Cash Items | 63.68M | -3.9M | -59.43M | -38.92M | n/a | 7.96M | 2.68M | -3.34M | 4.14M | 2.69M | 6.44M | -1.68M | 7.77M | 26.31M | 58.65M | -63.13M | 1.02M |
Deferred Income Tax | -1.6M | -358K | -313K | -337K | n/a | -8.51M | -190K | -4.03M | 283K | -5.35M | -6.42M | 1.18M | 2.18M | -12.8M | -3.44M | 11.2M | -921K |
Change in Working Capital | n/a | n/a | 34.77M | 36.11M | n/a | 11.38M | -25.07M | 7.23M | -16.93M | 77.44M | -68.05M | -10.03M | -4.79M | -13.23M | -4.68M | 7.93M | -10.15M |
Operating Cash Flow | 90.9M | 16.63M | 3.27M | 33.98M | n/a | 19.3M | 15.4M | 25.8M | 7.72M | 84.94M | -35.87M | 9.02M | 24.04M | -12.19M | 51.24M | 21.33M | 9.95M |
Capital Expenditures | -4.49M | n/a | 13.44M | -2.29M | n/a | -7.06M | -4.11M | -2.52M | -14.85M | -886K | -3.21M | -1.36M | -17.49M | -2.8M | -9.06M | -7.27M | -98K |
Cash Acquisitions | n/a | n/a | -140.56M | -1.03M | n/a | -1.84M | -5.72M | 350K | -325K | -11.06M | -4.86M | -109K | -2.43M | 2.36M | -7.81M | 1.54M | n/a |
Purchase of Investments | n/a | n/a | -8.36M | -3.93M | n/a | -2.03M | -103K | -3.02M | -1M | -104K | n/a | -1.73M | -21K | -26.99M | 4.11M | -4.79M | -332K |
Sales Maturities Of Investments | n/a | n/a | 124K | 124K | n/a | 491K | n/a | n/a | n/a | 25.23M | -42K | 6.48M | 200K | 66.51M | n/a | n/a | 1.11M |
Other Investing Acitivies | 1.02M | n/a | -2.94M | -1.09M | n/a | -997K | -24.94M | 2K | 2.14M | 16K | 21K | 4.21M | 219K | 15K | 10K | 15K | 16K |
Investing Cash Flow | -3.47M | n/a | -138.3M | -8.23M | n/a | -11.43M | -34.88M | -5.19M | -14.04M | 13.2M | -8.09M | 7.5M | -19.73M | 39.08M | -12.74M | -10.49M | 692K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | 9.69M | n/a | n/a | -503K | -150K | n/a | -9.54M | 398K | -168K | -9.25M | -230K | n/a | -2.76M | -2.64M | -342K |
Dividend Paid | -6.23M | n/a | -2.27M | -218K | n/a | -59.81M | -1.42M | -722K | -120K | -1.35M | -120K | -11.38M | -1.18M | n/a | -9.98M | -21.11M | -4K |
Other Financial Acitivies | -46.58M | n/a | 10.84M | -153.26M | n/a | -4.96M | 914K | -241K | -6.98M | 7.22M | -6.13M | -8.86M | 1.71M | 1.44M | -1.04M | -18.32M | 1.27M |
Financial Cash Flow | -52.81M | n/a | 8.57M | -153.48M | n/a | 11.99M | -510K | -963K | -7.1M | 5.87M | -6.25M | -20.24M | 532K | 1.44M | -11.02M | -39.43M | 1.26M |
Net Cash Flow | n/a | n/a | n/a | n/a | n/a | 19.87M | -19.98M | 19.65M | -13.41M | 104.01M | -50.21M | -3.72M | 4.84M | 28.33M | 27.48M | -28.59M | 11.91M |
Free Cash Flow | 86.41M | 16.63M | 16.71M | 31.69M | n/a | 12.24M | 11.3M | 23.29M | -7.13M | 84.05M | -39.08M | 7.67M | 6.55M | -14.99M | 42.18M | 14.07M | 9.85M |